Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

6.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.9K
Overview of Cell Death01:30

Overview of Cell Death

10.6K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.6K
Apoptosis01:30

Apoptosis

16.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.3K
Autophagic Cell Death01:18

Autophagic Cell Death

4.8K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

5.4K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SIGLEC12 mediates plasma membrane rupture during necroptotic cell death.

Nature·2025
Same author

Dynamic Prediction of the Risk of Hepatocellular Carcinoma After DAA Treatment for Hepatitis C Patients.

Cancer control : journal of the Moffitt Cancer Center·2025
Same author

Optical orthogonal chirp division multiplexing with chirp index modulation.

Optics letters·2025
Same author

Holomorphic embedding method for large-scale reverse osmosis desalination optimization.

Communications engineering·2025
Same author

Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study.

Diabetes, obesity & metabolism·2025
Same author

Shear-induced rotation enhances protein adsorption.

Colloids and surfaces. B, Biointerfaces·2025

Related Experiment Video

Updated: Mar 3, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis
05:30

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Published on: November 14, 2025

497

Necroptosis and Cancer.

Ayaz Najafov1, Hongbo Chen1,2, Junying Yuan1

  • 1Department of Cell Biology, Harvard Medical School, 240 Longwood Ave. Boston, MA 02115.

Trends in Cancer
|April 29, 2017
PubMed
Summary

Necroptosis, a programmed cell death, is implicated in cancer progression and inflammation. Understanding its role is key to developing novel cancer therapies targeting this cell death pathway.

Keywords:
cancercross-primingimmunitymetastasisnecroptosistherapy

More Related Videos

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.4K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K

Related Experiment Videos

Last Updated: Mar 3, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis
05:30

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis

Published on: November 14, 2025

497
Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.4K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K

Area of Science:

  • * Molecular Biology
  • * Immunology
  • * Oncology

Background:

  • * Necroptosis is a programmed lytic cell death pathway implicated in inflammatory disorders.
  • * Deregulation of programmed cell death and inflammation are significant factors in cancer development.
  • * Investigating necroptosis in cancer is crucial due to its role in metastasis and T cell death.

Purpose of the Study:

  • * To review the interplay between necroptosis and cancer.
  • * To outline key biological questions for targeting necroptosis in cancer therapy.

Main Methods:

  • * Literature review of recent studies on necroptosis and cancer.
  • * Analysis of the biological roles and therapeutic potential of necroptosis.

Main Results:

  • * Necroptosis can promote cancer metastasis and T cell death.
  • * Loss of RIPK3 expression is a mechanism for escaping necroptosis in some cancers.
  • * Necroptosis represents a promising, yet under-investigated, target for cancer therapies.

Conclusions:

  • * Further research into necroptosis's biological role in carcinogenesis is warranted.
  • * Targeting necroptosis holds potential for novel cancer treatment strategies.